A method using angiotensin converting enzyme immobilized on magnetic beads for inhibitor screening

J Pharm Biomed Anal. 2019 Feb 5:164:223-230. doi: 10.1016/j.jpba.2018.09.054. Epub 2018 Sep 29.

Abstract

Angiotensin converting enzyme (ACE), fusing with FLAG tag, was overexpressed in human embryonic kidney 293T cells. This recombinant FLAG-tagged ACE was immobilized on anti-FLAG antibody coated magnetic beads by affinity method in crude cell lysate for the first time. The enzyme-immobilized magnetic beads (ACE-MB), without further cleavage procedure, were used directly to establish a cost-effective and reliable method for screening ACE inhibitors by coupling with fluorescence detection. The enzymatic activity of the ACE-MB was validated based on its Michaelian kinetic behavior towards hippuryl-histidyl-leucine by UHPLC-MS/MS method firstly. Then, several conditions were optimized including amount of magnetic beads, incubation temperature and time in the procedure of ACE immobilization and amount of ACE-MB in the microplate operation. Moreover, this screening assay was validated with Z' factors between 0.71 and 0.81 using four known ACE inhibitors (captopril, lisinopril, fosinopril and fosinoprilat). The developed method was applied for the screening of ACE inhibitors from a small compound library of 45 natural products. As a result, epiberberine and fangchinoline with certain ACE inhibitory activities were screened out in the assay and validated. The results demonstrate the usefulness of this screening method using ACE immobilized on magnetic beads and the advantage of great efficiency with respect to both time and reagents for screening ACE inhibitors.

Keywords: Angiotensin converting enzyme; FLAG tag; High throughput screening; Magnetic beads; Recombinant enzyme.

Publication types

  • Evaluation Study
  • Validation Study

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / analysis*
  • Angiotensin-Converting Enzyme Inhibitors / chemistry
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Benzylisoquinolines / analysis
  • Benzylisoquinolines / chemistry
  • Benzylisoquinolines / pharmacology
  • Berberine / analogs & derivatives
  • Berberine / analysis
  • Berberine / chemistry
  • Berberine / pharmacology
  • Chromatography, Affinity / economics
  • Chromatography, Affinity / instrumentation
  • Chromatography, Affinity / methods
  • Chromatography, High Pressure Liquid / economics
  • Chromatography, High Pressure Liquid / instrumentation
  • Chromatography, High Pressure Liquid / methods
  • Cost-Benefit Analysis
  • Drug Evaluation, Preclinical / economics
  • Drug Evaluation, Preclinical / instrumentation
  • Drug Evaluation, Preclinical / methods*
  • Enzyme Assays / instrumentation
  • Enzyme Assays / methods
  • Enzymes, Immobilized / chemistry*
  • Enzymes, Immobilized / isolation & purification
  • HEK293 Cells
  • Humans
  • Oligopeptides / chemistry
  • Peptidyl-Dipeptidase A / chemistry*
  • Peptidyl-Dipeptidase A / isolation & purification
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / isolation & purification
  • Tandem Mass Spectrometry / economics
  • Tandem Mass Spectrometry / instrumentation
  • Tandem Mass Spectrometry / methods

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Benzylisoquinolines
  • Enzymes, Immobilized
  • Oligopeptides
  • Recombinant Proteins
  • Berberine
  • epiberberine
  • fangchinoline
  • FLAG peptide
  • ACE protein, human
  • Peptidyl-Dipeptidase A